These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5513975)

  • 1. The measurement of binding constants using circular dichroism. Binding of phenylbutazone and oxyphenbutazone.
    Rosen A
    Biochem Pharmacol; 1970 Jun; 19(6):2075-81. PubMed ID: 5513975
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of albumin conformation on binding of phenylbutazone and oxyphenbutazone to human serum albumin.
    Abd Elbary A; Vallner JJ; Whitworth CW
    J Pharm Sci; 1982 Feb; 71(2):241-4. PubMed ID: 7062254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric properties of the oxyphenbutazone--human serum albumin complex.
    Dröge JH; Janssen LH; Wilting J
    Pharm Weekbl Sci; 1983 Oct; 5(5):228-33. PubMed ID: 6646989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical studies of drug-protein complexes. V. The interaction of phenylbutazone, flufenamic acid, and dicoumarol with acetylsalicylic acid-treated human serum albumin.
    Chignell CF; Starkweather DK
    Mol Pharmacol; 1971 May; 7(3):229-37. PubMed ID: 4105907
    [No Abstract]   [Full Text] [Related]  

  • 5. Binding of phenylbutazone to human serum albumin. Characterization and identification of binding sites.
    Russeva V; Mihailova D
    Arzneimittelforschung; 1999 Mar; 49(3):255-8. PubMed ID: 10219470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the tryptophan and drug-binding properties of human serum albumin fragments by affinity chromatography and circular dichroism measurements.
    Sjöholm I; Ljungstedt I
    J Biol Chem; 1973 Dec; 248(24):8434-41. PubMed ID: 4148670
    [No Abstract]   [Full Text] [Related]  

  • 7. The binding of sodium warfarin to plasma albumin and its displacement by phenylbutazone.
    O'Reilly RA
    Ann N Y Acad Sci; 1973 Nov; 226():293-308. PubMed ID: 4520398
    [No Abstract]   [Full Text] [Related]  

  • 8. A supercritical fluid chromatographic method using packed columns for phenylbutazone and oxyphenbutazone in serum, and for phenylbutazone in a dosage form.
    Simmons BR; Jagota NK; Stewart JT
    J Pharm Biomed Anal; 1995 Jan; 13(1):59-64. PubMed ID: 7718635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on the allosteric interaction between the major binding sites of human serum albumin using microcalorimetry.
    Dröge JH; Janssen LH; Wilting J
    Biochim Biophys Acta; 1985 Mar; 827(3):396-402. PubMed ID: 3970944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational effects in the interaction of phenylbutazone with albumin studied by circular dichroism.
    Watanabe S; Saito T
    Biochem Pharmacol; 1992 Mar; 43(5):931-5. PubMed ID: 1554390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular dichroic examination of the interaction of some planar acidic drugs with tryptophan-modified human serum albumin.
    Vallner JJ; Perrin JH
    J Pharm Pharmacol; 1981 Nov; 33(11):697-700. PubMed ID: 6171635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chronic dose-ranging study of the pharmacokinetics of phenylbutazone in rheumatoid arthritic patients.
    Higham C; Aarons L; Holt PJ; Lynch M; Rowland M
    Br J Clin Pharmacol; 1981 Aug; 12(2):123-9. PubMed ID: 7306426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INHIBITION OF PROTEIN DENATURATION BY ANTIRHEUMATIC OR ANTIPHLOGISTIC AGENTS.
    MIZUSHIMA Y
    Arch Int Pharmacodyn Ther; 1964 May; 149():1-7. PubMed ID: 14169882
    [No Abstract]   [Full Text] [Related]  

  • 14. Cricular dichroism studies of drug-protein complexes.
    Chignell CF
    Life Sci; 1968 Nov; 7(22):1181-6. PubMed ID: 5716617
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of bumadizone, phenylbutazone and oxyphenbutazone in human plasma by high-performance liquid chromatography (author's transl)].
    Spahn H; Mutschler E
    Arzneimittelforschung; 1981; 31(3):495-9. PubMed ID: 6894379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein binding of piroxicam studied by means of affinity chromatography and circular dichroism.
    Russeva V; Zhivkova Z; Prodanova K; Rakovska R
    J Pharm Pharmacol; 1999 Jan; 51(1):49-52. PubMed ID: 10197417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug interactions. II. Binding of some pyrazolone and pyrazolidine derivatives to bovine serum albumin.
    Ozeki S; Tejima K
    Chem Pharm Bull (Tokyo); 1974 Jun; 22(6):1297-301. PubMed ID: 4472458
    [No Abstract]   [Full Text] [Related]  

  • 18. The circular dichroism spectra of the complexes of 1-anilino-8-naphthalenesulfonate with bovine serum albumin. Evidence for heterogeneity of binding.
    Anderson SR
    Biochemistry; 1969 Dec; 8(12):4838-42. PubMed ID: 5391862
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of pH on the benzodiazepine-human serum albumin complex. Circular dichroism studies.
    Müller W; Wollert U
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(1):67-82. PubMed ID: 4277537
    [No Abstract]   [Full Text] [Related]  

  • 20. A STUDY OF STRUCTURE--ACTIVITY RELATIONSHIPS IN REGARD TO SPECIES DIFFERENCE IN THE PHENYLBUTAZONE SERIES.
    PEREL JM; SNELL MM; CHEN W; DAYTON PG
    Biochem Pharmacol; 1964 Sep; 13():1305-17. PubMed ID: 14221728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.